<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00852475</url>
  </required_header>
  <id_info>
    <org_study_id>CARA-030-08F</org_study_id>
    <secondary_id>HP-00040456</secondary_id>
    <nct_id>NCT00852475</nct_id>
  </id_info>
  <brief_title>Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome</brief_title>
  <acronym>MUFAPUFA</acronym>
  <official_title>Comparative Effects of Two Popular Diets in Veterans With the Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine the effects of 2 commonly used diets, a Mediterranean
      monounsaturated fatty acid enriched (MUFA) or AHA polyunsaturated (PUFA) enriched diet
      combined with the VA Managing Overweight/Obesity for Veterans Everywhere (MOVE!) program so
      as to determine which one is superior in reducing cardiometabolic risk factors associated
      with Metabolic Syndrome. The risk factors considered include lipids and lipoproteins,
      inflammatory markers such as CRP and adiponectin, endothelium-dependent flow-mediated
      vasodilatation (FMD) and the postprandial lipid responses to a meal.

      Cardiometabolic risk factors will be determined by measuring several cardiovascular risk
      associated parameters including:

      Biochemical measurements of lipids and inflammatory markers, body composition and VO2max
      (Specific Objective 1, Descriptive).

      Postprandial response to a meal challenge and endothelial vasoreactivity (FMD) assessed by
      BART (Specific Objective 2, Physiological).

      Determination of the effects on postheparin lipases and transfer protein activity, visceral
      adipose tissue (VAT) and homeostasis model assessment-estimated insulin resistance (HOMA-IR)
      (Specific Objective 3, Mechanistic)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Metabolic Syndrome (MetS) is a common problem among Veterans and is associated with a
      greater likelihood of cardiovascular disease (CVD). The Mediterranean diet is the only
      popular diet that has been shown to reduce CVD event rates but the extent to which
      monounsaturated fatty acid (MUFA) or polyunsaturated fatty acid (PUFA) enrichment results in
      improvement in parameters of MetS is unresolved. Similarly, while low intensity exercise
      improves the CVD risk factor profile, there have been no comparative investigations comparing
      MUFA and PUFA enriched diets and exercise in patients with MetS that have extended beyond 1
      year. Recently, the VA established the MOVE! program, a national weight management program
      designed to help Veterans lose weight. Using the VA promoted program, we will perform a
      systematic evaluation of the effects of dietary fat composition [comparison between
      MUFA-enriched and PUFA enriched diet] with MOVE!. We hypothesize that a MUFA-enriched diet
      consisting of antioxidant, lipid reducing and insulin sensitizing properties will be superior
      to the less palatable PUFA-enriched diet on improving cardiometabolic parameters associated
      with MetS. Specifically, the MUFA MOVE! program is expected to lead to greater improvements
      than the PUFA MOVE! program in body composition and aerobic fitness (Specific Aim 1),
      endothelial dependent flow mediated vasodilatation and the postprandial lipid response to a
      meal load (Specific Aim 2) and the mechanisms (lipolytic and lipid transfer protein activity,
      homeostasis model assessment-estimated insulin resistance) responsible for these effects
      (Specific Aim 3). Collectively, these studies will advance our understanding of mechanisms
      underlying the differential effects of MUFA and PUFA-enriched dietary regimens on
      cardiometabolic health and when combined with the MOVE! program, will provide new and useful
      information to Veterans (and the general public) interested in optimizing their diets for CVD
      disease prevention and improved vascular health.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Changes in Veterans With MetS.</measure>
    <time_frame>6 months from Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelium-dependent FMD Assessed by the Brachial Artery Reactivity Test (BART) at Rest .</measure>
    <time_frame>6 months from Baseline</time_frame>
    <description>Ultrasonographic imaging of the brachial artery (BART) was used to assess endothelium-dependent flow-mediated vasodilation (FMD) in participants at rest. To do this,the blood pressure cuff is inflated to 200 mm Hg and kept inflated for 5 minutes. On immediate release of the cuff, the brachial artery was imaged within 1 minute after cuff release.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>MUFA</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Assignment to monounsaturated enriched diet with exercise. This represents the MUFA MOVE! program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PUFA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assignment to polyunsaturated enriched diet with exercise. This represents the PUFA MOVE! program</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>MUFA MOVE! (Monounsaturated fatty enriched diet)</intervention_name>
    <description>MUFA MOVE!diet and exercise program</description>
    <arm_group_label>MUFA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PUFA MOVE! (Polyunsaturated fatty acid enriched diet)</intervention_name>
    <description>PUFA MOVE! diet and exercise program</description>
    <arm_group_label>PUFA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Presence of 3 or more of the following):

          -  Waist circumference &gt;102 cm in men or &gt;88 cm women

          -  Treated Hypertension or Untreated Blood pressure &gt;130/85 and &lt; 160/100 mm Hg

          -  Treated Hyperglycemia or Untreated Fasting blood glucose (FBG) &gt;100 mg/dL (based on
             2006 guidelines)

          -  Treated Hyperlipidemia or Untreated Triglycerides &gt; 150 mg/dL

          -  HDL-C &lt; 40 mg/dL men &lt; 50 mg/dL women

        Exclusion Criteria:

          -  Decompensated heart failure (NYHA Class IV);

          -  Severe Pulmonary disease (Unable to walk on a treadmill at 2.5 mph or greater);

          -  Chronic renal insufficiency (Cr &gt; 2.5 mg/dL)

          -  Treated diabetes mellitus with FBG &gt; 180 mg/dL or HbA1C &gt;9g %

          -  Hematologic or malignant disorders

          -  Treated SBP &gt;160 mmHg and/or DBP &gt; 95 mmHg ;

          -  Treated TG &gt; 250 mg/dL

          -  Use of systemic vasodilators (e.g., nitrates)

          -  Morbid Obesity (BMI &gt; 50 kg/m2)

          -  Endocrine (thyroid) or metabolic disorders (unless treated and under control)

          -  Alcohol consumption greater than (2) 4-ounce glasses of table wine, (2) 12-oz bottles
             of beer or 2 shots of spirits in men or women

          -  Active IV drug abuse within the past 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Maryland Health Care System, Baltimore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Maryland Health Care System, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2009</study_first_submitted>
  <study_first_submitted_qc>February 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2009</study_first_posted>
  <results_first_submitted>December 22, 2014</results_first_submitted>
  <results_first_submitted_qc>December 7, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 2, 2017</results_first_posted>
  <last_update_submitted>December 7, 2016</last_update_submitted>
  <last_update_submitted_qc>December 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MUFA</keyword>
  <keyword>PUFA</keyword>
  <keyword>MOVE! program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>MUFA</title>
          <description>Assignment to monounsaturated enriched diet (in the form of enriched muffins or oils) with exercise. This represents the MUFA MOVE! program
MUFA MOVE! (Monounsaturated fatty enriched diet): MUFA MOVE! diet and exercise program</description>
        </group>
        <group group_id="P2">
          <title>PUFA</title>
          <description>Assignment to polyunsaturated enriched diet (in the form of enriched muffins or oils) with exercise. This represents the PUFA MOVE! program
PUFA MOVE! (Polyunsaturated fatty acid enriched diet): PUFA MOVE! diet and exercise program</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>MUFA</title>
          <description>Assignment to monounsaturated enriched diet with exercise. This represents the MUFA MOVE! program
MUFA MOVE! (Monounsaturated fatty enriched diet): MUFA MOVE!diet and exercise program</description>
        </group>
        <group group_id="B2">
          <title>PUFA</title>
          <description>Assignment to polyunsaturated enriched diet with exercise. This represents the PUFA MOVE! program
PUFA MOVE! (Polyunsaturated fatty acid enriched diet): PUFA MOVE! diet and exercise program</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="46"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weight Changes in Veterans With MetS.</title>
        <time_frame>6 months from Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MUFA</title>
            <description>Assignment to monounsaturated enriched diet with exercise. This represents the MUFA MOVE! program
MUFA MOVE! (Monounsaturated fatty enriched diet): MUFA MOVE!diet and exercise program</description>
          </group>
          <group group_id="O2">
            <title>PUFA</title>
            <description>Assignment to polyunsaturated enriched diet with exercise. This represents the PUFA MOVE! program
PUFA MOVE! (Polyunsaturated fatty acid enriched diet): PUFA MOVE! diet and exercise program</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Changes in Veterans With MetS.</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="0.99"/>
                    <measurement group_id="O2" value="-6.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Endothelium-dependent FMD Assessed by the Brachial Artery Reactivity Test (BART) at Rest .</title>
        <description>Ultrasonographic imaging of the brachial artery (BART) was used to assess endothelium-dependent flow-mediated vasodilation (FMD) in participants at rest. To do this,the blood pressure cuff is inflated to 200 mm Hg and kept inflated for 5 minutes. On immediate release of the cuff, the brachial artery was imaged within 1 minute after cuff release.</description>
        <time_frame>6 months from Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MUFA Arm</title>
            <description>Assessment of FMD after six months of MUFA enrichment</description>
          </group>
          <group group_id="O2">
            <title>PUFA Arm</title>
            <description>Assessment of FMD after 6 months of PUFA enrichment</description>
          </group>
        </group_list>
        <measure>
          <title>Endothelium-dependent FMD Assessed by the Brachial Artery Reactivity Test (BART) at Rest .</title>
          <description>Ultrasonographic imaging of the brachial artery (BART) was used to assess endothelium-dependent flow-mediated vasodilation (FMD) in participants at rest. To do this,the blood pressure cuff is inflated to 200 mm Hg and kept inflated for 5 minutes. On immediate release of the cuff, the brachial artery was imaged within 1 minute after cuff release.</description>
          <units>percentage of change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.29"/>
                    <measurement group_id="O2" value="1.5" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>MUFA</title>
          <description>subjects received a diet enriched in MUFA</description>
        </group>
        <group group_id="E2">
          <title>PUFA</title>
          <description>subjects received a diet enriched in PUFA</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Miller, MD</name_or_title>
      <organization>Baltimore VAMC and University of Maryland Medical Center</organization>
      <phone>4103286299</phone>
      <email>mmiller@medicine.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

